课题基金 / 基金详情

项目摘要

项目成果

DAVID HEIMBROOK的其他基金

相似基金

相关文献

中文摘要
翻译
为了全面了解与接触工程纳米材料相关的潜在健康风险,详细了解工程纳米材料的物理和化学特性至关重要。关于ENM生物学反应的大多数已发表文献未提供详细的理化表征数据,以确定哪些材料特性对观察到的生物学反应至关重要。ENM的物理化学性质(如大小、电荷、疏水性、表面化学等)的细微变化对环境的影响。因此,生物学反应在很大程度上是未知的。一个新的3500万美元(超过五年)的研究计划(NIEHS纳米技术健康影响研究中心,[NCNHIR])成立于2010年,专注于发展的物理化学特性如何影响他们的理解与生物基质在细胞,分子和器官水平的相互作用,以及如何将这些信息整合到开发预测建模系统,以评估潜在的健康影响。NCNHIR组成了一个联合体,研究人员将使用一组通用的ENM沿着他们研究计划中提出的项目。为了方便访问这些受让人,并获得由该财团研究的ENM的标准化物理化学特性数据,NIEHS与NCI/SAIC Fredrick的纳米技术表征实验室(NCL)签订了合同。
英文摘要
To derive a comprehensive understanding on the potential health risks associated with exposure to engineered nanomaterials (ENMs), a detailed understanding of the physical and chemical characteristics of the ENMs is critical. The majority of the published literature on the biological responses to ENMs does not provide detailed physicochemical characterization data to identify which of the material's characteristics are critical to observed biological responses. The effects of subtle changes in the physicochemical properties of ENMs (such as size, charge, hydrophobicity, surface chemistry, etc.) on the biological response are therefore largely unknown. A new $35M (over five years) research program (NIEHS Centers for Nanotechnology Health Implications Research, [NCNHIR]) established in 2010 is focused on developing an understanding of how physicochemical characteristics of ENMs influence their interactions with biological matrices at the cell, molecular and organ level, and how this information can be integrated to develop predictive modeling systems to assess potential health effects. The NCNHIR formed a consortium and the investigators will be working with a common set of ENMs along with project's proposed in their research plan. To facilitate access to these grantees and to get a standardized physicochemical characteristics data for the ENMs to be studied by this consortium NIEHS established a contract with Nanotechnology Characterization Laboratory (NCL) at NCI/SAIC Fredrick.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Therapeutically Applicable Research to Generate Effective Treatments (TARGET)
  • 批准号:
    8654778
  • 项目类别:
  • 资助金额:
    $35.0万
  • 财政年份:
    2008
  • 负责人:
    DAVID HEIMBROOK
  • 依托单位:
DCTD Drug Development Project Management
  • 批准号:
    8654757
  • 项目类别:
  • 资助金额:
    $2077.28万
  • 财政年份:
    2008
  • 负责人:
    DAVID HEIMBROOK
  • 依托单位:
Genotyping for epidemiology studies
  • 批准号:
    8654773
  • 项目类别:
  • 资助金额:
    $526.19万
  • 财政年份:
    2008
  • 负责人:
    DAVID HEIMBROOK
  • 依托单位:
Image Analysis Laboratory - EML and OM combined
  • 批准号:
    8429264
  • 项目类别:
  • 资助金额:
    $171.0万
  • 财政年份:
    2008
  • 负责人:
    DAVID HEIMBROOK
  • 依托单位:
海外基金